|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Biomolecular Screening, Vol. 10, No. 2,
157-167 (2005)
DOI: 10.1177/1087057104272394
Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators
Stewart Leung
Berlex Biosciences, Richmond, CA
April Holbrook
Berlex Biosciences, Richmond, CA
Beverly King
Berlex Biosciences, Richmond, CA
Hong-Tao Lu
Berlex Biosciences, Richmond, CA
Vincent Evans
Berlex Biosciences, Richmond, CA
Neil Miyamoto
Berlex Biosciences, Richmond, CA
Cornell Mallari
Berlex Biosciences, Richmond, CA
Susan Harvey
Berlex Biosciences, Richmond, CA
Dave Davey
Berlex Biosciences, Richmond, CA
Elena Ho
Berlex Biosciences, Richmond, CA
Wei-Wei Li
Berlex Biosciences, Richmond, CA
John Parkinson
Berlex Biosciences, Richmond, CA
Richard Horuk
Berlex Biosciences, Richmond, CA
Stefan Jaroch
Schering AG, Berlin, Germany
Markus Berger
Schering AG, Berlin, Germany
Werner Skuballa
Schering AG, Berlin, Germany
Christopher West
Berlex Biosciences, Richmond, CA
Rebecca Pulk
Berlex Biosciences, Richmond, CA
Gary Phillips
Berlex Biosciences, Richmond, CA
Judi Bryant
Berlex Biosciences, Richmond, CA
Babu Subramanyam
Berlex Biosciences, Richmond, CA
Caralee Schaefer
Berlex Biosciences, Richmond, CA
Hugh Salamon
Berlex Biosciences, Richmond, CA
Eric Lyons
Berlex Biosciences, Richmond, CA
Daniela Schilling
Schering AG, Berlin, Germany
Henrik Seidel
Schering AG, Berlin, Germany
Joern Kraetzschmar
Schering AG, Berlin, Germany
Michael Snider
Berlex Biosciences, Richmond, CA
Daniel Perez
Berlex Biosciences, Richmond, CA
Effector functions and proliferation of T helper (Th) cells are influenced by cytokines in the environment. Th1 cells respond to a synergistic effect of interleukin-12 (IL-12) and interleukin-18 (IL-18) to secrete interferon-gamma (IFN- ). In contrast, Th2 cells respond to interleukin-4 (IL-4) to secrete IL-4, interleukin-13 (IL-13), interleukin-5 (IL-5), and interleukin-10 (IL-10). The authors were interested in identifying nonpeptide inhibitors of the Th1 response selective for the IL-12/IL-18-mediated secretion of IFN- while leaving the IL-4-mediated Th2 cytokine secretion relatively intact. The authors established a screening protocol using human peripheral blood mononuclear cells (PBMCs) and identified the hydrazino anthranilate compound 1 as a potent inhibitor of IL-12/IL-18-mediated IFN- secretion from CD3+ cells with an IC50 around 200 nM. The inhibitor was specific because it had virtually no effect on IL-4-mediated IL-13 release from the same population of cells. Further work established that compound 1 was a potent intracellular iron chelator that inhibited both IL-12/IL-18- and IL-4-mediated T cell proliferation. Iron chelation affects multiple cellular pathways in T cells. Thus, the IL-12/IL-18-mediated proliferation and IFN- secretion are very sensitive to intracellular iron concentration. However, the IL-4-mediated IL-13 secretion does not correlate with proliferation and is partially resistant to potent iron chelation
Key Words: Th1 response iron chelators T helper cells cytokines

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K.M. Mitchell, A.L. Dotson, K.M. Cool, A. Chakrabarty, S.H. Benedict, and S.M. LeVine
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis
Multiple Sclerosis,
November 1, 2007;
13(9):
1118 - 1126.
[Abstract]
[PDF]
|
 |
|
|